Clinical Trials
8 trialsNCT06979596 2026-05-13
OMAHA-015
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT01953926 2024-03-12
SUMMIT
Puma Biotechnology, Inc.
Phase 2 Terminated
NCT00313170 2020-01-06
FINDER II
AstraZeneca
Phase 2 Completed
NCT00274469 2019-09-06
FIRST
AstraZeneca
Phase 2 Completed
NCT02530411 2015-08-21
FURVA
Velindre NHS Trust
Phase 2 Unknown
NCT00534417 2013-02-01
Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Accelerated Community Oncology Research Network
Phase 2 Completed
NCT00305448 2012-02-15
FINDER I
AstraZeneca
Phase 2 Completed
NCT00357110 2010-12-21
@FAME
AstraZeneca
Phase 2 Completed